Executive record

Brendan Hannah

Brendan Hannah signed IRulya Therapeutics Inc.'s 10-K as Chief Business Officer and Chief Operating Officer and Chief Compliance Officer (Principal Financial Officer and Principal Accounting Officer), filed April 10, 2026.

1 verified record · 1 company

Career line from the records

1

Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.

  1. 2026-04-1010-K signatureIRulya Therapeutics Inc.

    Signed the annual report as Chief Business Officer and Chief Operating Officer and Chief Compliance Officer (Principal Financial Officer and Principal Accounting Officer)

    10-K filed April 10, 2026 · sec.gov

Companies

1

IRulya Therapeutics Inc.QNCX

Biological Products, (No Diagnostic Substances)

This page lists only verified filing records that name Brendan Hannah, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.